Actively Recruiting
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
Led by Tongji Hospital · Updated on 2025-05-07
165
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Exploring the ED90 of remimazolam in Drug-induced Sleep Endoscopy in adults at different BMI groups.
CONDITIONS
Official Title
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years old
- ASA physical status classification I to II
- Signed informed consent form
You will not qualify if you...
- History of central nervous system diseases, cognitive, mental, or communication disorders
- Serious cardiovascular, respiratory, liver, or kidney disease
- Anticipated need for tracheal intubation or laryngeal mask
- Allergy to benzodiazepines or opioids
- Use of sedative, analgesic, or antidepressant drugs within 24 hours
- Abnormal liver or kidney function
- Recent participation in other clinical studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hospital
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
M
mujun chang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here